Skip to content

Clinical trials

Phase 2 Lung Diseases, Interstitial trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 2 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20141
20151
20172
20201
20222
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
AllRock Bio, Inc.1
Avalyn Pharma Inc.1
Biogen1
Bristol-Myers Squibb1
Furiex Pharmaceuticals, Inc1
Hoffmann-La Roche1
Insmed Incorporated1
Matthias Griese1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial14
Hypertension, Pulmonary4
Idiopathic Pulmonary Fibrosis4
Idiopathic Interstitial Pneumonias3
Pulmonary Fibrosis3
Fibrosis2
Lung Diseases2
Pulmonary Arterial Hypertension2
Respiratory Tract Diseases2
Alveolitis, Extrinsic Allergic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.